| Literature DB >> 35327481 |
Jakub Toczek1, Marcin Sadłocha1, Katarzyna Major1, Rafał Stojko1.
Abstract
It is intractable to manage the vast majority of wounds in a classical surgical manner, however if silver, likewise gold and its representative nanoparticles, can lead to the amelioration of the wound healing process after extensive procedures, they should be employed in the current gynecological practice as promptly as possible. Most likely due to its antimicrobial properties, silver is usually applied as an additional component in the wound healing process. In wound management, we obtained various aspects that can lead to impaired wound healing; the crucial aspect for the wound milieu is to prevent the offending agents from occurring. The greatest barrier to healing is represented by the bacterial biofilm, which can occur naturally or in other ways. Biofilm bacteria can produce extracellular polymers, which can then resist concentrated anti-bacterial treatment. The published literature on the use of silver nanoparticles' utilization in wound healing becomes slightly heterogenous and requires us in difficult moments to set up proper treatment guidelines.Entities:
Keywords: antimicrobial nanomaterials; gold; nanoparticles; silver; wound healing
Year: 2022 PMID: 35327481 PMCID: PMC8945154 DOI: 10.3390/biomedicines10030679
Source DB: PubMed Journal: Biomedicines ISSN: 2227-9059
Biomaterial-based immunomodulators, reproduced from Wright JB, Lam K, Buret AG, Olson ME, Burrell RE. Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 2002; 10:141–151.) and Forlee M, Rossington A, Searle R. A prospective, open, multicenter study to evaluate a new gelling fiber dressing containing silver in the management of venous leg ulcers. Int Wound J 2014; 11:438–445.
| Pharmaceutical | Effect | Outcomes | Species |
|---|---|---|---|
| Silver and Gold dressings | Antimicrobial, Inhibit MMPs, Formation of granulation tissue | Augumentation of wound healing | Daily Practice available |
| Si-RNA | Regulation of immune cell infiltration + Subside protease activity | Amelioration of wound closure | Diabetic mouse |
| MiR-99 | Regulation of PI3k/AKT pathway | Increase wound closure | Diabetic mouse |
| MALP-2 | Infiltration of macrophages and activation | Influence early wound closure | Diabetic mouse |
| PRP gel | Source of cytokines and growth factors | Boost healing in diabetic ulcer | Phase I |
Figure 1Therapeutic strategies target: Red-acceleration, Blue-Inhibition. Reproduced from Wilgus TA. Immune cells in the healing skin wound: influential players at each stage of repair. Pharmacol. Res. 2008; 58:112–116. and Tan J, Wu J. Current progress in understanding the molecular pathogenesis of burn scar contracture. Burns Trauma 2017; 5:14.